MRI scans aim to predict tysabri success in MS patients
NCT ID NCT02904876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether special MRI scans can detect early brain changes in people with multiple sclerosis who are starting treatment with Tysabri. Researchers planned to follow 70 patients for two years, comparing MRI images before and after treatment. The goal was to find imaging markers that could predict how well someone responds to the drug. However, the study was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tysabri (natalizumab)
- What this could lead to
- If successful, this could help doctors predict which MS patients will respond well to Tysabri using MRI scans.
- What could go wrong
- The study was terminated early, so results are limited. It was also small and exploratory, meaning findings may not be conclusive or widely applicable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Neurologie Hôpital de Hautepierre
Strasbourg, Alsace, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?